[An analysis of adhered cells on the surface of F-heparin surface modified intraocular lenses implanted into rhesus monkeys' eyes].

OBJECTIVE: To study the biocompatibility of F-heparin surface modified intraocular lenses (IOLs) by observing cellular reaction on the surface of IOLs implanted into the rhesus monkeys' eyes. METHODS: Ten monkeys (20 eyes) were classified into two groups. PMMA IOLs and F-heparin modified IOLs were respectively implanted into 10 monkeys' eyes. The IOLs were examined with computer image analysis, light microscope (LM) and scanning electron microscope (SEM) at postoperative 180 and 360 days. RESULTS: A few of adhered cells were on the surface of the central part of the IOL and more on the border of the IOL optics. The giant cells deposited on the surface occupied the largest area and the number of the macrophages was the greatest. The cells deposited on the surface of the IOLs in the F-heparin modified group were less than that in the non-modified group. In the modified group, there was fine granular proteinaceous membrane on the surface of the IOLs, but in the non-modified group there was fibrinous reticular proteinaceous membrane. CONCLUSION: The biocompatibility of the F-heparin surface modified IOLs is better than that of non-modified PMMA IOLs.

[Evaluation of midazolam intravenous sedated patient's comfort degree in mandibular third molar surgery].

OBJECTIVE: To evaluate the clinical efficacy and safety of continuous low-flow intravenous infusion of midazolam sedation in mandibular third molar surgery. METHODS: Fifty healthy patients with symmetrically placed impacted bilateral mandibular third molars were included in this self controlled, randomized clinical study. Degree of comfort (their actual current anxiety level) was assessed using a visual analogue scale (VAS) of pain and anxiety. Patients' satisfaction and degree of amnesia were also evaluated. Vital signs and oxygen saturation were recorded. RESULTS: Low dose midazolam sedation obviously increased the degree of patients' comfort and satisfaction. Vital signs and oxygen saturation levels did not differ significantly between the two groups. CONCLUSIONS: Midazolam as an intravenous sedation agent in mandibular third molar surgery showed satisfactory effect on patients with mild dental fear.